A Study of Dulaglutide in Healthy Participants

Summary

The purpose of this study is to evaluate a new formulation of dulaglutide (study drug) administered under the skin as one injection using a single dose pen compared to three injections using a pre filled syringe. This study will evaluate how much of the study drug enters the body and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study will last about 84 days, including screening and will require overnight stays in the clinical research unit (CRU).

Timeline

Start

2017-12-07

Primary completion

2018-06-06

Completion

2018-06-06

Drugs

Indications

No indication recorded.